<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="45602">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02512588</url>
  </required_header>
  <id_info>
    <org_study_id>BTD-001 IH201</org_study_id>
    <nct_id>NCT02512588</nct_id>
  </id_info>
  <brief_title>A Study of Safety and Efficacy of BTD-001 in Treatment of Patients With Idiopathic Hypersomnia (IH) or Narcolepsy Type 2</brief_title>
  <official_title>A Randomized, Placebo-Controlled, Double-blind, Fixed-Dose, Multiple Cohort, Multiple Crossover, Dose-Finding Study of Oral BTD-001 in Adults With Idiopathic Hypersomnia (IH) or Narcolepsy Type 2</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Balance Therapeutics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Balance Therapeutics</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized, placebo-controlled, double-blind, multiple cohort, fixed-dose multiple
      crossover, dose-finding study of oral BTD-001 in adult patients with IH or Narcolepsy
      without cataplexy (Type 2).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2015</start_date>
  <completion_date type="Anticipated">January 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Participant, Investigator</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy Epworth Sleepiness Scale</measure>
    <time_frame>After 14 days per treatment</time_frame>
    <description>Epworth Sleepiness Scale</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Efficacy Maintenance of Wakefulness Test</measure>
    <time_frame>After 14 days per treatment</time_frame>
    <description>Maintenance of Wakefulness Test</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Pharmacokinetics (Cmax)</measure>
    <time_frame>Selected Days 14, 35, and 56</time_frame>
    <description>Pharmacokinetic parameters after multiple doses.
-Maximum serum concentration (Cmax)</description>
  </other_outcome>
  <other_outcome>
    <measure>Pharmacokinetics (Tmax)</measure>
    <time_frame>Selected Days 14, 35, and 56</time_frame>
    <description>Pharmacokinetic parameters after multiple doses.
-Time of maximum plasma concentration (Tmax)</description>
  </other_outcome>
  <other_outcome>
    <measure>Pharmacokinetics (T½)</measure>
    <time_frame>Selected Days 1, 14, 31, 35, 42, and 56</time_frame>
    <description>Pharmacokinetic parameters after multiple doses.
-Elimination half life (T½)</description>
  </other_outcome>
  <other_outcome>
    <measure>Pharmacokinetics (AUC)</measure>
    <time_frame>Selected Days 1, 14, 21, 35, 42, and 56</time_frame>
    <description>Pharmacokinetic parameters after multiple doses.
-Area under the concentration time curve (AUC)</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Idiopathic Hypersomnia</condition>
  <condition>Narcolepsy Without Cataplexy</condition>
  <arm_group>
    <arm_group_label>BTD-001</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>BTD-001</intervention_name>
    <arm_group_label>BTD-001</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Meets ICSD-3 criteria for IH or Narcolepsy Type 2 and not undergoing pharmacologic
             treatment for the condition

          -  Usual nightly total sleep at least 6 hours as single major rest period without naps

          -  Epworth Sleepiness Scale of 10 or greater

          -  Males or females age 18 to 65 years

        Exclusion Criteria:

          -  Any disorder causing hypersomnia other than IH or Narcolepsy Type 2

          -  Usual bedtime later than midnight

          -  Seizure disorder or history of syncope, unexplained loss of consciousness or seizure
             in the past 3 years

          -  Beck Depression Inventory score greater than 19

          -  Beck Anxiety Inventory score greater than 15

          -  Significant history of or current suicidal ideation or behavior

          -  BMI less than 18 kg/m2 or greater than 39 kg/m2

          -  Positive toxicology screen or breathalyzer test

          -  Clinically significant abnormal findings on safety assessments

          -  Any significant medical or psychiatric disease or any condition that would put the
             patient at risk by participating in the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Patricia Walicke, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Balance Therapeutics, Inc.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Heather Jividen</last_name>
    <phone>(650) 650 489-1271</phone>
    <email>heather.jividen@balance-therapeutics.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Sleep Disorders Center of Alabama</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35213</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Doekel, MD</last_name>
      <phone>205-599-1020</phone>
    </contact>
    <investigator>
      <last_name>Robert Doekel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stanford Medicine Sleep Center</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94304</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emmanuel Mignot, MD</last_name>
      <phone>650-736-6607</phone>
    </contact>
    <investigator>
      <last_name>Emmanuel Mignot, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pacific Research Network</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephen Thein, PhD</last_name>
      <phone>619-294-4302</phone>
    </contact>
    <investigator>
      <last_name>Stephen Thein, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Empire Clinical Research</name>
      <address>
        <city>Upland</city>
        <state>California</state>
        <zip>91786</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yogesh Paliwal, MD</last_name>
      <phone>909-981-5321</phone>
    </contact>
    <investigator>
      <last_name>Yogesh Paliwal, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Natee Poopat, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>REM Sleep Medicine, Colorado Sleep Institute</name>
      <address>
        <city>Boulder</city>
        <state>Colorado</state>
        <zip>80301</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John Harsh</last_name>
      <phone>720-279-9098</phone>
    </contact>
    <investigator>
      <last_name>John Harsh, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>PAB Clinical Research</name>
      <address>
        <city>Brandon</city>
        <state>Florida</state>
        <zip>33511</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniel Lorch, MD</last_name>
      <phone>813-657-1584</phone>
    </contact>
    <investigator>
      <last_name>Daniel Lorch, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinical Research Group of St. Petersburg</name>
      <address>
        <city>St. Petersburg</city>
        <state>Florida</state>
        <zip>33707</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Neil Feldman, MD</last_name>
      <phone>727-360-0853</phone>
    </contact>
    <investigator>
      <last_name>Neil Feldman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Emory University School of Medicine Emory Sleep Center</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30329</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Romy Hoque, MD</last_name>
      <phone>404-712-7533</phone>
    </contact>
    <investigator>
      <last_name>Romy Hoque, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>NeuroTrials Research Inc</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30342</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Russell Rosenberg, MD</last_name>
      <phone>404-851-9934</phone>
    </contact>
    <investigator>
      <last_name>Russell Rosenberg, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>SleepMed of Central</name>
      <address>
        <city>Macon</city>
        <state>Georgia</state>
        <zip>31201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Charles Wells, MD</last_name>
      <phone>478-745-5779</phone>
    </contact>
    <investigator>
      <last_name>Charles Wells, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kentucky Research Group,</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40218</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Winslow, MD</last_name>
      <phone>502-479-1217</phone>
    </contact>
    <investigator>
      <last_name>David Winslow, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Center for Sleep and Wake Disorders</name>
      <address>
        <city>Chevy Chase</city>
        <state>Maryland</state>
        <zip>20815</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Helene Emsellem, MD</last_name>
      <phone>301-654-5665</phone>
    </contact>
    <investigator>
      <last_name>Helene Emsellem, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Neurocare, Inc.</name>
      <address>
        <city>Newton</city>
        <state>Massachusetts</state>
        <zip>02459</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Robert Thomas, MD</last_name>
      <phone>617-667-4849</phone>
    </contact>
    <investigator>
      <last_name>Robert Thomas, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clayton Sleep Institute</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <zip>63143</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joseph Ojile, MD</last_name>
      <phone>314-645-6005</phone>
    </contact>
    <investigator>
      <last_name>Joseph Ojile, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Wake Research Associates</name>
      <address>
        <city>Raleigh</city>
        <state>North Carolina</state>
        <zip>27612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Singar Jagadeesan, MD</last_name>
      <phone>919-781-2514</phone>
    </contact>
    <investigator>
      <last_name>Singar Jagadeesan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>NorthCoast Clinical Trials</name>
      <address>
        <city>Beachwood</city>
        <state>Ohio</state>
        <zip>44122</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bijan Bastani, MD</last_name>
      <phone>216-514-1803</phone>
    </contact>
    <investigator>
      <last_name>Bijan Bastani, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Community Research Management Assoc.</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45255</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>James Maynard, MD</last_name>
      <phone>513-281-3868</phone>
      <phone_ext>3100</phone_ext>
    </contact>
    <investigator>
      <last_name>James Maynard, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lynn Institute</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73112</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>William Orr, PhD</last_name>
      <phone>405-447-8839</phone>
    </contact>
    <investigator>
      <last_name>William Orr, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>SleepMed of South Carolina</name>
      <address>
        <city>Columbia</city>
        <state>South Carolina</state>
        <zip>29201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Richard Bogan, MD</last_name>
      <phone>803-251-3093</phone>
    </contact>
    <investigator>
      <last_name>Richard Bogan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Future Search Trials of Neurology</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78731</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John Hudson, MD</last_name>
      <phone>512-380-9925</phone>
    </contact>
    <investigator>
      <last_name>John Hudson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Houston Sleep Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77063</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Todd Swick, MD</last_name>
      <phone>713-465-7066</phone>
    </contact>
    <investigator>
      <last_name>Todd Swick, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sleep Therapy and Research</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>James Andry, MD</last_name>
      <phone>210-614-6000</phone>
    </contact>
    <investigator>
      <last_name>James Andry, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Swedish Medical Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98122</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah Stolz, MD</last_name>
      <phone>206-320-6006</phone>
    </contact>
    <investigator>
      <last_name>Sarah Stolz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.arisestudies.com</url>
    <description>ARISE Study Website</description>
  </link>
  <verification_date>March 2017</verification_date>
  <lastchanged_date>March 27, 2017</lastchanged_date>
  <firstreceived_date>July 23, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Narcolepsy</mesh_term>
    <mesh_term>Cataplexy</mesh_term>
    <mesh_term>Disorders of Excessive Somnolence</mesh_term>
    <mesh_term>Hypersomnolence, Idiopathic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
